Results 271 to 280 of about 163,674 (312)
Some of the next articles are maybe not open access.

Treatment of ST-elevation Myocardial Infarction

Future Cardiology, 2008
In patients with ST-segment elevation myocardial infarction (STEMI), timely and adequate treatment may improve the prognosis dramatically. Restoration of the infarct vessel patency is one of the cornerstones of initial treatment. Compared with fibrinolytic therapy, primary percutaneous coronary intervention (PCI) results in improved short- and long ...
Rik, Hermanides, Jan Paul, Ottervanger
openaire   +2 more sources

[Echocardiography in ST-elevation myocardial infarction].

Giornale italiano di cardiologia (2006), 2018
Echocardiography is an imaging technique of paramount importance for the management of patients with ST-elevation myocardial infarction. In particular, this technique may be useful for diagnosis and is essential for prognosis and to guide drug therapy.
Mele, Donato   +5 more
openaire   +2 more sources

Transradial Intervention in ST Elevation Myocardial Infarction

Current Cardiology Reports, 2015
Primary percutaneous coronary intervention (PPCI) in ST elevation myocardial infarction (STEMI) represents the current gold standard reperfusion therapy. Recent advances in antiplatelet and anticoagulant therapy have reduced the risk of ischemic complications and mortality in PPCI although this has been at the expense of major bleeding complications ...
Mustafa, Ahmad H S   +6 more
openaire   +2 more sources

ST elevation: differentiation between ST elevation myocardial infarction and nonischemic ST elevation

Journal of Electrocardiology, 2011
It is well accepted that early reperfusion is beneficial in patients with acute myocardial infarction presenting with ST elevation (STE). Earlier studies suggested lack of beneficial effects in patients presenting without STE and even with ST depression.
Henry D, Huang, Yochai, Birnbaum
openaire   +2 more sources

Biomarkers and ST-elevation myocardial infarction

Heart, 2013
In the recent Heart paper, Cuculi et al 1 from Oxford University challenge two conventional wisdoms in clinical cardiology: first, biomarkers do not have a role in the management of patients presenting with suspected ST-elevation myocardial infarction (STEMI); and second, in the absence of cardiogenic shock, there is no remaining unmet clinical need in
openaire   +2 more sources

ST-Elevation Myocardial Infarction Track

Therapeutic Hypothermia and Temperature Management, 2021
Benjamin S, Abella   +3 more
openaire   +2 more sources

Acute ST Elevation Myocardial Infarction

2020
Acute myocardial infarction (AMI) remains a major public health issue and is the leading cause of death in the United States. ST elevation myocardial infarction is a syndrome that is comprised of clinical signs and symptoms of myocardial ischemia, electrocardiographic changes of ST elevation in two or more contiguous leads of at least 2 mm in men and ...
Satya Shreenivas, Scott Lilly
openaire   +1 more source

ST-Elevation Myocardial Infarction

American Journal of Critical Care, 2002
Mary G, Adams, Michele M, Pelter
openaire   +2 more sources

Myocardial infarction (ST-elevation).

BMJ clinical evidence, 2016
About a quarter of people having an acute myocardial infarction (MI) in the USA will die of it, half of them within 1 hour of the onset of symptoms. Cardiogenic shock develops in over 5% of people surviving the first hour after an acute MI, with a mortality of 50-80% in the first 48 hours.We conducted a systematic review and aimed to answer the ...
openaire   +2 more sources

ST-segment elevation myocardial infarction

2015
Acute myocardial infarction with ST-segment elevation is a common and dramatic manifestation of coronary artery disease. It is caused by the rupture of an atherosclerotic plaque in a coronary artery, leading to its total thrombotic occlusion and resultant ischaemia and necrosis of downstream myocardium.
Adrian Cheong   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy